FDA's Top Drug Regulator to Retire Amid Agency Turmoil
TL;DR Summary
Richard Pazdur, the top FDA drug regulator, plans to retire just weeks after starting the job, amid concerns over the agency's legal and procedural approaches to drug approvals, contributing to recent instability at the FDA.
- Top FDA drug regulator plans to depart weeks into job The Washington Post
- FDA drug chief signals possible exit as agency turmoil deepens The Guardian
- The FDA’s top drug regulator submits his resignation to the agency Politico
- Pazdur to retire weeks after assuming leadership of CDER FirstWord Pharma
- US FDA's newly appointed drugs chief set to retire Reuters
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
72%
123 → 35 words
Want the full story? Read the original article
Read on The Washington Post